Fri Jan 10 15:45:07 UTC 2025: ## Bharat Biotech Chairman Dr. Krishna Ella Awarded Prestigious Indian Science Fellowship
**New Delhi, January 11, 2025** – Dr. Krishna Ella, co-founder and Executive Chairman of Bharat Biotech International, has been awarded the India Fellowship of the Indian National Science Academy (INSA) for 2025. This marks the first year the INSA has extended fellowships to industry representatives.
Dr. Ella’s contributions to vaccine development were cited as the reason for the award, highlighting Bharat Biotech’s achievements, including Covaxin, the world’s first clinically proven conjugated Typhoid Vaccine (ROTAVAC), and the first preservative-free Hepatitis B Vaccine (Revac-B mcf). The company also developed India’s first cell-cultured Swine Flu vaccine and manufactures the world’s most affordable Hepatitis vaccines, and was the first globally to develop a Zika virus vaccine.
Dr. Ella shared the honor with other distinguished scientists and technologists, including former chairmen of the Atomic Energy Commission and ISRO, a former DRDO Director General, and the co-founder of Infosys. A total of 61 fellowships were awarded this year.
In a statement, Dr. Ella expressed his gratitude for the recognition and pledged to continue supporting INSA’s initiatives to improve public health and establish India as a leader in vaccine innovation. He also acknowledged the contributions of his team at Bharat Biotech.
First Piper 